Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1994 Aug;38(8):1716–1720. doi: 10.1128/aac.38.8.1716

Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever.

M D Smith 1, N M Duong 1, N T Hoa 1, J Wain 1, H D Ha 1, T S Diep 1, N P Day 1, T T Hien 1, N J White 1
PMCID: PMC284627  PMID: 7986000

Abstract

An open, randomized comparison of ofloxacin (200 mg, every 12 h) given orally for 5 days and ceftriaxone (3 g, once daily) given intravenously for 3 days in the treatment of uncomplicated enteric fever was conducted in Ho Chi Minh City, Vietnam. Salmonella paratyphi type A was isolated from six patients. Salmonella typhi was isolated from 41 patients; 63% of these isolates were resistant to multiple antibiotics: ampicillin, chloramphenicol, sulfamethoxazole, trimethoprim, and tetracycline. Of the culture-confirmed cases, treatment with ofloxacin resulted in complete cure of all 22 patients, whereas 18 of 25 patients treated with ceftriaxone were completely cured (P < 0.01). In the ceftriaxone group, there were six acute treatment failures and one relapse. Mean +/- standard deviation fever clearance times were 81 +/- 25 h for ofloxacin and 196 +/- 87 h for ceftriaxone (P < 0.0001). Short-course treatment with oral ofloxacin (5 days) is significantly better than that with ceftriaxone (3 days) and will be of particular benefit in areas where multiresistant strains of S. typhi are encountered.

Full text

PDF
1720

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albert M. J., Haider K., Nahar S., Kibriya A. K., Hossain M. A. Multiresistant Salmonella typhi in Bangladesh. J Antimicrob Chemother. 1991 Apr;27(4):554–555. doi: 10.1093/jac/27.4.554. [DOI] [PubMed] [Google Scholar]
  2. Altwegg M., Hickman-Brenner F. W., Farmer J. J., 3rd Ribosomal RNA gene restriction patterns provide increased sensitivity for typing Salmonella typhi strains. J Infect Dis. 1989 Jul;160(1):145–149. doi: 10.1093/infdis/160.1.145. [DOI] [PubMed] [Google Scholar]
  3. Anand A. C., Kataria V. K., Singh W., Chatterjee S. K. Epidemic multiresistant enteric fever in eastern India. Lancet. 1990 Feb 10;335(8685):352–352. doi: 10.1016/0140-6736(90)90635-i. [DOI] [PubMed] [Google Scholar]
  4. Ayyagari A., Pal N. Outbreak of typhoid fever due to multiresistant Salmonella typhi in northern India--a preliminary report. Trans R Soc Trop Med Hyg. 1991 Mar-Apr;85(2):302–302. doi: 10.1016/0035-9203(91)90066-8. [DOI] [PubMed] [Google Scholar]
  5. Bhutta Z. A., Farooqui B. J., Sturm A. W. Eradication of a multiple drug resistant Salmonella paratyphi A causing meningitis with ciprofloxacin. J Infect. 1992 Sep;25(2):215–219. doi: 10.1016/0163-4453(92)94173-u. [DOI] [PubMed] [Google Scholar]
  6. Butler T., Linh N. N., Arnold K., Adickman M. D., Chau D. M., Muoi M. M. Therapy of antimicrobial-resistant typhoid fever. Antimicrob Agents Chemother. 1977 Apr;11(4):645–650. doi: 10.1128/aac.11.4.645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chang H. R., Vladoianu I. R., Pechère J. C. Effects of ampicillin, ceftriaxone, chloramphenicol, pefloxacin and trimethoprim-sulphamethoxazole on Salmonella typhi within human monocyte-derived macrophages. J Antimicrob Chemother. 1990 Nov;26(5):689–694. doi: 10.1093/jac/26.5.689. [DOI] [PubMed] [Google Scholar]
  8. Chew S. K., Monteiro E. H., Lim Y. S., Allen D. M. A 7-day course of ciprofloxacin for enteric fever. J Infect. 1992 Nov;25(3):267–271. doi: 10.1016/0163-4453(92)91519-h. [DOI] [PubMed] [Google Scholar]
  9. Esteban E., Snipes K., Hird D., Kasten R., Kinde H. Use of ribotyping for characterization of Salmonella serotypes. J Clin Microbiol. 1993 Feb;31(2):233–237. doi: 10.1128/jcm.31.2.233-237.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Islam A., Butler T., Kabir I., Alam N. H. Treatment of typhoid fever with ceftriaxone for 5 days or chloramphenicol for 14 days: a randomized clinical trial. Antimicrob Agents Chemother. 1993 Aug;37(8):1572–1575. doi: 10.1128/aac.37.8.1572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Islam A., Butler T., Nath S. K., Alam N. H., Stoeckel K., Houser H. B., Smith A. L. Randomized treatment of patients with typhoid fever by using ceftriaxone or chloramphenicol. J Infect Dis. 1988 Oct;158(4):742–747. doi: 10.1093/infdis/158.4.742. [DOI] [PubMed] [Google Scholar]
  12. Lasserre R., Sangalang R. P., Santiago L. Three-day treatment of typhoid fever with two different doses of ceftriaxone, compared to 14-day therapy with chloramphenicol: a randomized trial. J Antimicrob Chemother. 1991 Nov;28(5):765–772. doi: 10.1093/jac/28.5.765. [DOI] [PubMed] [Google Scholar]
  13. Mandal B. K. Modern treatment of typhoid fever. J Infect. 1991 Jan;22(1):1–4. doi: 10.1016/0163-4453(91)90758-k. [DOI] [PubMed] [Google Scholar]
  14. Meskin S., Jacob M. S., Macaden R., Keystone J. S., Kozarsky P. E., Ramachadran A. N., Metchock B. Short-course treatment of typhoid fever with ciprofloxacin in south India. Trans R Soc Trop Med Hyg. 1992 Jul-Aug;86(4):446–447. doi: 10.1016/0035-9203(92)90264-d. [DOI] [PubMed] [Google Scholar]
  15. Mourad A. S., Metwally M., el Deen A. N., Threlfall E. J., Rowe B., Mapes T., Hedstrom R., Bourgeois A. L., Murphy J. R. Multiple-drug-resistant Salmonella typhi. Clin Infect Dis. 1993 Jul;17(1):135–136. doi: 10.1093/clinids/17.1.135. [DOI] [PubMed] [Google Scholar]
  16. Ramirez C. A., Bran J. L., Mejia C. R., Garcia J. F. Open, prospective study of the clinical efficacy of ciprofloxacin. Antimicrob Agents Chemother. 1985 Jul;28(1):128–132. doi: 10.1128/aac.28.1.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rowe B., Ward L. R., Threlfall E. J. Ciprofloxacin and typhoid fever. Lancet. 1992 Mar 21;339(8795):740–740. [PubMed] [Google Scholar]
  18. Rowe B., Ward L. R., Threlfall E. J. Treatment of multiresistant typhoid fever. Lancet. 1991 Jun 8;337(8754):1422–1422. doi: 10.1016/0140-6736(91)93116-q. [DOI] [PubMed] [Google Scholar]
  19. Soe G. B., Overturf G. D. Treatment of typhoid fever and other systemic salmonelloses with cefotaxime, ceftriaxone, cefoperazone, and other newer cephalosporins. Rev Infect Dis. 1987 Jul-Aug;9(4):719–736. doi: 10.1093/clinids/9.4.719. [DOI] [PubMed] [Google Scholar]
  20. Stanley P. J., Flegg P. J., Mandal B. K., Geddes A. M. Open study of ciprofloxacin in enteric fever. J Antimicrob Chemother. 1989 May;23(5):789–791. doi: 10.1093/jac/23.5.789. [DOI] [PubMed] [Google Scholar]
  21. Wang F., Gu X. J., Zhang M. F., Tai T. Y. Treatment of typhoid fever with ofloxacin. J Antimicrob Chemother. 1989 May;23(5):785–788. doi: 10.1093/jac/23.5.785. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES